• SENSEX
    NIFTY 50
Business

COVID-19 treatment: Cipla in licensing agreement with Gilead for antiviral drug remdesivir

Updated : May 13, 2020 07:21 PM IST

Cipla is one of the three Indian companies that have partnered with Gilead for remdesivir
Cipla will receive the manufacturing know-how from Gilead Sciences to manufacture the API and finished product on a commercial scale
COVID-19 treatment: Cipla in licensing agreement with Gilead for antiviral drug remdesivir

You May Also Like

Live TV
Advertisement